Cerus Stock Price

0.05 (0.79%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cerus Corp CERS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 0.79% 6.36 00:00:00
Close Price Low Price High Price Open Price Previous Close
6.34 6.25 6.41 6.35 6.31
Bid Price Ask Price Spread News
5.76 7.00 1.24 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,700 846,035 $ 6.33 $ 5,358,505 1,257,655 2.71 - 9.00
Last Trade Time Type Quantity Stock Price Currency
16:52:44 formt 329 $ 6.36 USD

Cerus Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.06B 166.17M 162.68M $ 93.77M $ -58.06M -0.52 -18.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 111.89k 2.60%

more financials information »

Cerus News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CERS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.496.756.086.371,042,580-0.13-2.0%
1 Month5.887.0055.86016.421,312,4900.488.16%
3 Months7.049.005.596.521,397,590-0.68-9.66%
6 Months5.319.004.916.351,722,0321.0519.77%
1 Year4.449.002.715.501,617,9241.9243.24%
3 Years3.069.002.715.521,163,9013.30107.84%
5 Years4.609.001.935.251,119,7421.7638.26%

Cerus Description

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: blood safety and generates revenue from the same.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.